down arrow

Nephros, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6406714005
USD
3.30
0.04 (1.23%)

Jun 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Nortech Systems, Inc.
NeurAxis, Inc.
STRATA Skin Sciences, Inc.
Nutriband, Inc.
Nephros, Inc.
NeuroOne Medical Technologies Corp.
Acutus Medical, Inc.
Inspira Technologies Oxy B.H.N. Ltd.
Modular Medical, Inc.
Check-Cap Ltd.
SmileDirectClub, Inc.

Why is Nephros, Inc. ?

1
Poor Management Efficiency with a low ROE of 1.72%
  • The company has been able to generate a Return on Equity (avg) of 1.72% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 17.67% of over the last 5 years
3
Negative results in Mar 26
  • PRE-TAX PROFIT(Q) At USD 0.14 MM has Fallen at -53.57%
  • NET PROFIT(Q) At USD 0.14 MM has Fallen at -53.1%
  • OPERATING CASH FLOW(Y) Lowest at USD -0.35 MM
4
With ROE of 11.70%, it has a expensive valuation with a 3.02 Price to Book Value
  • Over the past year, while the stock has generated a return of -23.08%, its profits have risen by 112% ; the PEG ratio of the company is 0
5
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 22.24% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -23.08% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nephros, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Nephros, Inc.
-23.08%
0.56
91.04%
S&P 500
22.24%
1.67
13.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
17.03%
EBIT Growth (5y)
17.67%
EBIT to Interest (avg)
-2.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.40
Sales to Capital Employed (avg)
1.64
Tax Ratio
1.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
53.06%
ROCE (avg)
2.77%
ROE (avg)
1.72%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
3.02
EV to EBIT
22.47
EV to EBITDA
20.01
EV to Capital Employed
4.96
EV to Sales
1.37
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
22.07%
ROE (Latest)
11.70%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
INVENTORY TURNOVER RATIO(HY)

Highest at 2.8 times

NET SALES(Q)

Highest at USD 5.21 MM

-19What is not working for the Company
PRE-TAX PROFIT(Q)

At USD 0.14 MM has Fallen at -53.57%

NET PROFIT(Q)

At USD 0.14 MM has Fallen at -53.1%

OPERATING CASH FLOW(Y)

Lowest at USD -0.35 MM

RAW MATERIAL COST(Y)

Grown by 11.13% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 6.17 times

Here's what is working for Nephros, Inc.

Net Sales
Highest at USD 5.21 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Inventory Turnover Ratio
Highest at 2.8 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Nephros, Inc.

Pre-Tax Profit
At USD 0.14 MM has Fallen at -53.57%
over average net sales of the previous four periods of USD 0.3 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD 0.14 MM has Fallen at -53.1%
over average net sales of the previous four periods of USD 0.3 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -0.35 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Debtors Turnover Ratio
Lowest at 6.17 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 11.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."